Browse by Medical Category
Go To Programs
Go To Specialties
Go To Specialties
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Joshua Hirsch, MD, is director of Endovascular/Interventional Neuroradiology; chief of the NeuroInterventional Spine Service; co-director of the Neuroendovascular Program; vice chair of Interventional Radiology and associate professor at Harvard Medical School. He has extensive experience in diagnosis, management and treatment of cerebrovascular disease including aneurysms, AVMs, dural arteriovenous fistulas, pre-operative tumor embolization and treatment of head/neck lesions including epistaxis. He is a specialist in minimally invasive spine surgery, acute stroke treatment with thrombolysis and stroke prevention using carotid and vertebral artery angioplasty and stenting.
Dr. Hirsch has published over 300 papers and many chapters in peer-reviewed literature and is a founding editor of the Journal of NeuroInterventional Surgery. He is vice president of the American Society of Spine Radiology and on the board of the American Society of Interventional Pain Physicians and the Society for Injectable Osteoarticular Biomaterials. He is past president of the Society of NeuroInterventional Surgery and treasurer of its foundation; an active member and fellow of the American College of Radiology and the Society of Interventional Radiology; an advisor to the RUC for the American Society of Neuroradiology; and member of the Niekro Foundation's Medical Advisory Board.
Dr. Hirsch has a medical degree from the University of Pennsylvania School of Medicine. He completed an internship in medicine at Pennsylvania Hospital; a residency/fellowship in radiology/neuroradiology at the Hospital of the University of Pennsylvania; and a fellowship in interventional neuroradiology at Lahey Medical Center's Neurovascular Center.
Dr. Hirsch has been named one of America's Top Doctors and a Best of Boston physician for multiple years. He is a member of the Marquis Who's Who and was recently awarded the 100 designation from the MGH's Cancer Center
Dr. Hirsch has multiple research interests and actively publishes extensively in the peer-reviewed literature. His research includes cerebrovascular disease and minimally invasive options to treat cerebrovascular conditions such as intracranial aneurysms (both ruptured and unruptured), arterio-venous malformations and large vessel occlusion leading to stroke. As a result of this research, Dr. Hirsch has led the development of multiple clinical guidelines for cerebrovascular disease and is invited around the world to lecture on these topics.Dr. Hirsch's research includes many important projects related to percutaneous augmentation. He has authored one of the largest series in the peer-reviewed literature for the minimally invasive treatment of both malignant and benign vertebral compression fractures. Most recently, he has focused on futuristic elements such as treatment of new sites and new theories of treatment. Concurrently, Dr. Hirsch has been very active in defining standards for systematic reviews and meta-analyses in interventional pain management (IPM). To that end, he has published extensively in the IPM space. Additionally, Dr. Hirsch has published extensively on socioeconomic issues, health care policy, interventional operations management, comparative effectiveness research and evidence-based clinical practice. Dr. Hirsch is a founding editor of the Journal of NeuroInterventional Surgery, has served on the editorial board on many prestigious journals and has produced multiple podcasts in association with these various publications.
View my most recent publications at PubMed
In advance of the annual meeting of the North American Spine Society this week in Boston, neurointerventional radiologist and department vice chair Joshua A. Hirsch, MD talks about the landmark VAPOUR trial on vertebroplasty.
As part of the MGH’s commitment to quality and safety, Hotline will feature each of the 50 Patient Safety Stars throughout the remainder of the year, highlighting a portion of their standout nominations.
An active octogenarian, John Higgins walked up to four miles a day to stay fit. But one night last winter, he slipped on a sheet of ice. “I went down and hit my hip,” he says. He remembers the agony he felt on both sides and across the middle of his back. “I couldn’t take a step without excruciating pain. There was nothing I could do.”
Albert Arillotta did not think things could get much worse after he was diagnosed with cancer. A father of three children and an avid golfer, 52-year-old Arillotta enjoyed a healthy, active lifestyle until the day he received shocking news after a CT scan: he had kidney cancer.
Peer-reviewed medical journal on interventional pain management names Mass General radiologist as new editor-in-chief.
The Journal of NeuroInterventional Surgery (JNIS) has been accepted for inclusion in the Medline bibliographic database of the U.S. National Library of Medicine (NLM).
The SNIS is a national organization of physicians who have special expertise in treating such conditions as stroke, aneurysms, carotid stenosis and spinal abnormalities through minimally invasive procedures.
Nucleoplasty, a minimally invasive, image-guided treatment performed by Dr. Joshua Hirsch at Massachusetts General Hospital Imaging brought relief to a local woman suffering from herniated disc pain.
quotes MGH investigator Martin Hirsch
Listen to Joshua A. Hirsch, MD, vice chair, Interventional Radiology, discuss key points on intra-arterial treatment (I-AT) for ischemic stroke.
Albert Arillotta thought things couldn't get much worse after he was diagnosed with kidney cancer. But once it was treated, the real pain began.
Back to Top